Key Takeaways ISRG posted 20% worldwide procedure growth in Q3, led by da Vinci gains and rapid Ion expansion.ISRG saw utilization rise as 240 da Vinci 5 systems were placed, lifting the global installed base.ISRG generates 85% of revenues from recurring sales, driven by da Vinci 5 features and upgrades.Intuitive Surgical (ISRG) stock has delivered a strong recent run, rising 32.4% over the past three months and currently trading at $592.85, just 3.8$616 reached in February 2025 ...